Clinical Trials Logo

Gout Flare clinical trials

View clinical trials related to Gout Flare.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05936268 Recruiting - Gout Flare Clinical Trials

Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare

Gensci 048-203
Start date: June 30, 2023
Phase: Phase 2
Study type: Interventional

To evaluate the safety and efficacy of Genakumab for Injection in patients with gout flare as a first line therapy

NCT ID: NCT05658575 Recruiting - Arthritis Clinical Trials

Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare

Start date: January 6, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this trial is to investigate the efficacy and safety of dapansutrile (OLT1177®) tablets in subjects with an acute gout flare.

NCT ID: NCT05586971 Recruiting - Gout Clinical Trials

Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients

EURELIA2
Start date: March 30, 2023
Phase: Phase 3
Study type: Interventional

The aim of this 12-month randomized multi-regional double-blind parallel group allopurinol and placebo-controlled phase 3 study is to assess the efficacy and safety of three different doses of Tigulixostat in gout patients with hyperuricemia.

NCT ID: NCT05586958 Recruiting - Gout Clinical Trials

Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients

EURELIA1
Start date: October 25, 2022
Phase: Phase 3
Study type: Interventional

The aim of this 6-month randomized multi-regional double-blind parallel group placebo-controlled phase 3 study is to assess the efficacy and safety of three different doses of Tigulixostat in gout patients with hyperuricemia.

NCT ID: NCT03524222 Recruiting - Asthma Clinical Trials

Home Hospital for Suddenly Ill Adults

Start date: January 18, 2018
Phase: N/A
Study type: Interventional

The investigators propose a home hospital model of care that substitutes for treatment in an acute care hospital. Limited studies of the home hospital model have demonstrated that a sizeable proportion of acute care can be delivered in the home with equal quality and safety, reduced cost, and improved patient experience.